These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32387649)

  • 1. Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease.
    King AC; Wood TE; Rodriguez E; Parpura V; Gray M
    Exp Neurol; 2020 Aug; 330():113358. PubMed ID: 32387649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
    Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
    Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease.
    Oliveira AO; Osmand A; Outeiro TF; Muchowski PJ; Finkbeiner S
    Hum Mol Genet; 2016 May; 25(9):1677-89. PubMed ID: 26920069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
    Gray M; Shirasaki DI; Cepeda C; André VM; Wilburn B; Lu XH; Tao J; Yamazaki I; Li SH; Sun YE; Li XJ; Levine MS; Yang XW
    J Neurosci; 2008 Jun; 28(24):6182-95. PubMed ID: 18550760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice.
    Mantovani S; Gordon R; Li R; Christie DC; Kumar V; Woodruff TM
    Hum Mol Genet; 2016 May; 25(9):1780-91. PubMed ID: 26908618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
    Hult Lundh S; Nilsson N; Soylu R; Kirik D; Petersén Å
    Hum Mol Genet; 2013 Sep; 22(17):3485-97. PubMed ID: 23697793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Ca(2+)-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model.
    Lee W; Reyes RC; Gottipati MK; Lewis K; Lesort M; Parpura V; Gray M
    Neurobiol Dis; 2013 Oct; 58():192-9. PubMed ID: 23756199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.
    Wang N; Gray M; Lu XH; Cantle JP; Holley SM; Greiner E; Gu X; Shirasaki D; Cepeda C; Li Y; Dong H; Levine MS; Yang XW
    Nat Med; 2014 May; 20(5):536-41. PubMed ID: 24784230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in structure and function of diaphragm neuromuscular junctions from BACHD mouse model for Huntington's disease.
    de Aragão BC; Rodrigues HA; Valadão PA; Camargo W; Naves LA; Ribeiro FM; Guatimosim C
    Neurochem Int; 2016 Feb; 93():64-72. PubMed ID: 26796203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment.
    Gafni J; Papanikolaou T; Degiacomo F; Holcomb J; Chen S; Menalled L; Kudwa A; Fitzpatrick J; Miller S; Ramboz S; Tuunanen PI; Lehtimäki KK; Yang XW; Park L; Kwak S; Howland D; Park H; Ellerby LM
    J Neurosci; 2012 May; 32(22):7454-65. PubMed ID: 22649225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease.
    Kuljis DA; Gad L; Loh DH; MacDowell Kaswan Z; Hitchcock ON; Ghiani CA; Colwell CS
    PLoS One; 2016; 11(2):e0147583. PubMed ID: 26871695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of deletion of mutant huntingtin in steroidogenic factor 1 neurons on the psychiatric and metabolic phenotype in the BACHD mouse model of Huntington disease.
    Baldo B; Cheong RY; Petersén Å
    PLoS One; 2014; 9(10):e107691. PubMed ID: 25271967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions.
    Boussicault L; Hérard AS; Calingasan N; Petit F; Malgorn C; Merienne N; Jan C; Gaillard MC; Lerchundi R; Barros LF; Escartin C; Delzescaux T; Mariani J; Hantraye P; Beal MF; Brouillet E; Véga C; Bonvento G
    J Cereb Blood Flow Metab; 2014 Sep; 34(9):1500-10. PubMed ID: 24938402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
    Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
    Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
    Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
    J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.
    Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV
    J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior compared to wild-type littermates.
    Manfré G; Novati A; Faccini I; Rossetti AC; Bosch K; Molteni R; Riva MA; Van der Harst JE; Nguyen HP; Homberg JR
    PLoS One; 2018; 13(2):e0192289. PubMed ID: 29415038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.